Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model
Open accessThe DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.
Abstract
The 2015 European pulmonary hypertension (PH) guidelines propose a risk stratification strategy for patients with pulmonary arterial hypertension (PAH). Low-, intermediate- and high-risk strata are defined by estimated 1-year mortality risks of <5%, 5–10% and >10%, respectively. This risk assessment strategy awaits validation. We analysed data from patients with newly diagnosed PAH enrolled into COMPERA (Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension), a European-based PH registry. An abbreviated version of the risk assessment strategy proposed by the European PH guidelines was applied, using the following variables: World Health Organization functional class, 6-min walking distance, brain natriuretic peptide or its N-terminal fragment, right atrial pressure, cardiac index and mixed venous oxygen saturation. Data from 1588 patients were analysed. Mortality rates were significantly different between the three risk strata (p<0.001 for all comparisons). In the entire patient population, the observed mortality rates 1 year after diagnosis were 2.8% in the low-risk cohort (n=196), 9.9% in the intermediate-risk cohort (n=1116) and 21.2% in the high-risk cohort (n=276). In addition, the risk assessment strategy proved valid at follow-up and in major PAH subgroups. An abbreviated version of the risk assessment strategy proposed by the current European PH guidelines provides accurate mortality estimates in patients with PAH.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several European registries have since validated the ESC/ERS risk status model; however, it is unknown if the ESC/ERS tool predicts clinical worsening or hospitalizations.(288)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [288]
Citations
Cites
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationAuthors/Task Force Members, Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp297 · Cited by 3,846
Self-citationGaliè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citationMacitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
Pulido, T., Adzerikho, I., Channick, R. N., Delcroix, M., Galiè, N., Ghofrani, H.-A., Jansa, P., Jing, Z.-C., Le Brun, F.-O., Mehta, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213917 · Cited by 1,443
Self-citationInitial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
Galiè, N., Barberà, J. A., Frost, A. E., Ghofrani, H.-A., Hoeper, M. M., McLaughlin, V. V., Peacock, A. J., Simonneau, G., Vachiery, J.-L., Grünig, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1413687 · Cited by 1,182
Self-citationSelexipag for the Treatment of Pulmonary Arterial Hypertension
Sitbon, O., Channick, R., Chin, K. M., Frey, A., Gaine, S., Galiè, N., Ghofrani, H.-A., Hoeper, M. M., Lang, I. M., Preiss, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503184 · Cited by 1,060
Self-citationBenza, R. L., Gomberg-Maitland, M., Miller, D. P., Frost, A., Frantz, R. P., Foreman, A. J., Badesch, D. B., & McGoon, M. D. (2012) · Chest · doi:10.1378/chest.11-0676 · Cited by 557
Kylhammar, D., Kjellström, B., Hjalmarsson, C., Jansson, K., Nisell, M., Söderberg, S., Wikström, G., & Rådegran, G. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx257 · Cited by 540
Hoeper, M. M., Huscher, D., Ghofrani, H. A., Delcroix, M., Distler, O., Schweiger, C., Grunig, E., Staehler, G., Rosenkranz, S., Halank, M., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.10.026 · Cited by 466
Self-citationUpfront triple combination therapy in pulmonary arterial hypertension: a pilot study
Sitbon, O., Jaïs, X., Savale, L., Cottin, V., Bergot, E., Macari, E. A., Bouvaist, H., Dauphin, C., Picard, F., Bulifon, S., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00116313 · Cited by 382
Cited by
Items 601–700 of 739
Rebuttal From Drs Humbert and Lau
Humbert, M. J. C., & Lau, E. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.07.003
Group 1 Clinical Features and Treatment
Ruopp, N. F., & Waxman, A. B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11504-1
Ricardo Fritz, G., Felipe Aller, R., Joel Melo, T., Francisco Arancibia, H., & Mónica Zagolín, B. (2020) · Revista chilena de enfermedades respiratorias · doi:10.4067/s0717-73482020000100041
Zelt, J. G. E. (2020) · uO Research (University of Ottawa) · doi:10.20381/ruor-24965
Cardiac Catheterization in Pulmonary Hypertension
Kovács, G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11576-4
Bouzina, H. (2020) · Lund University Publications (Lund University)
Luknar, M., Lesný, P., Svetlošák, M., Hlivák, P., & Gonçalvesová, E. (2020) · Cardiology letters · doi:10.4149/cardiol_2020_4_11
Wernhart, S., Hedderich, J., & Weihe, E. (2021) · Journal of Cardiovascular and Thoracic Research · doi:10.34172/jcvtr.2021.05
“J Cardiovasc Thorac Res, 2021, 13(1), 68-78 70 aimed to set the thresholds of our combinatorial score either at the observed deflection points across the achieved workload or, in the absence of a visible deflection point, at established thresholds in the literature.”
BackgroundMethodInfluentialERS International Congress 2020: highlights from the Thoracic Surgery and Transplantation Assembly
Esendagli, D. R., Shah, U. B., Batıhan, G., Magouliotis, D. E., Meloni, F., Vos, R., Elia, S., & Hellemons, M. E. (2021) · ERJ Open Research · doi:10.1183/23120541.00743-2020
“The importance of risk stratification into low, intermediate and high risk was emphazised, in order to identify which subset of patients may benefit most from LTx while minimizing overall risk and resource utilization [39, 43,44].”
BackgroundAdvanced Surgical and Percutaneous Approaches to Pulmonary Vascular Disease
Piechura, L. M., Rinewalt, D. E., & Mallidi, H. R. (2021) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2020.10.003
Pulmonary hypertension: clinical phenotypes and non-invasive risk stratification
Lewis, R. A. (2020) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Church, C., Gin‐Sing, W., Grady, D., Johnson, M., Kiely, D. G., Lordan, J. L., Turner, N., Wort, S. J., & Condliffe, R. A. (2021) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.1931129
“Importantly, subsequent studies from the Swedish [19], COMPERA [20] and French Registries [21] have shown that patients who remained in or at follow-up moved into a low-risk group had a better survival compared to patients who remained in or moved into intermediate or highrisk groups.”
BackgroundHerkenrath, S.-D. (2021) · Kompass Pneumologie · doi:10.1159/000517974
Discovering Novel Biomarkers for Pulmonary Hypertension
Patel, N. (2018) · Annals of Advanced Biomedical Sciences · doi:10.23880/aabsc-16000105
Cardiopulmonary Monitoring of Patients with Pulmonary Hypertension and Right Ventricular Failure
Davey, R., Alohali, A. F., Jia, S., & Mehta, S. (2021) · Springer eBooks · doi:10.1007/978-3-030-73387-2_54
Alves, J. L. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2020.tde-15092021-111301
Gas exchange: the neglected piece in the PAH puzzle
Hassoun, P. M., Souza, R., & Hoeper, M. M. (2021) · European Respiratory Journal · doi:10.1183/13993003.01407-2021
Self-citationRescala, G., la Cruz, R. R.-D., & Robles, M. (2021) · NCT Neumología y Cirugía de Tórax · doi:10.35366/102478
Алгоритми діагностики та лікування ідіопатичної легеневої артеріальної гіпертензії
Sirenko, Y., Radchenko, G., Zhyvylo, I., & Botsiuk, Y. A. (2021) · HYPERTENSION · doi:10.22141/2224-1485.14.5.2021.245239
Sung, S., Yeh, W., Chiang, C., Huang, C., Huang, W., Chen, C., & Cheng, H. (2021) · Research Square · doi:10.21203/rs.3.rs-441254/v1
44/w mit Dyspnoe und Leistungsminderung: Vorbereitung auf die Facharztprüfung: Fall 103
Walthelm-Hösel, J., & Joa, F. (2022) · Der Internist · doi:10.1007/s00108-021-01215-6
“(Nach [5]) Prognoseparameter (geschätzte 1-Jahres-Mortalität) Geringes Risiko (<5%) Intermediäres Risiko (5–10%) Hohes Risiko (>10%)”
BackgroundLiu, R., zheng, Z., & Su, B. (2022) · Research Square · doi:10.21203/rs.3.rs-1223160/v1
Castaño-Cifuentes, O., Clavijo-Moldón, A. A., & Díaz, J. (2022) · Archivos de cardiolog�a de M�xico (English ed Internet) · doi:10.24875/acme.m22000275
(2020) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-19.2.i
Lessons from pulmonary hypertension registries
Humbert, M. J. C. (2018) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2018.09.008
Pérez, V. D. J. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734628293.793561130
Pulmonary Hypertension in Children: A Global View
Moledina, S., & Neumann, S. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-08-102723-3.00270-5
Garcia, M. V. F., Souza, R., & Caruso, P. (2022) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2022.06.019
Demerouti, E., & Tsiapras, D. P. (2022) · Journal of Clinical Cardiology · doi:10.33696/cardiology.3.031
Garcia, M. V. F. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2022.tde-19012023-101300
THANG ĐIỂM REVEAL LITE 2.0 TRONG TIÊN LƯỢNG NGƯỜI BỆNH TĂNG ÁP LỰC ĐỘNG MẠCH PHỔI NHÓM 1
Bùi, T. T. H., Nguyễn, T. B. Y., & Nguyễn, M. H. (2023) · Tạp chí Y học Việt Nam · doi:10.51298/vmj.v523i2.4527
Zuin, M., Bilato, C., Rigatelli, G., Quadretti, L., & Roncon, L. (2023) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001457
Garcia, M. V. F., Souza, R., & Caruso, P. (2023) · Medicina Intensiva · doi:10.1016/j.medin.2022.06.008
Interstitial lung diseases and secondary pulmonary hypertension
Belić, S., Marić, N., Đurđević, N., Golubovic, A., Milivojević, I., Geratović, M., Nikolić, N., Čokrlić, I., & Stjepanović, M. (2023) · Srpski medicinski casopis Lekarske komore · doi:10.5937/smclk4-41136
Right Ventricular Imaging for Predicting Risk in Pulmonary Arterial Hypertension
Thenappan, T., & Brittain, E. L. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.02.039
Camacho, R. E. C., Orozco‐Levi, M., Londoño, A., Acosta, D. F., Alvarado, J. J., Carvajal, J. F., Camargo-Mendoza, J. P., Gómez-Paláu, R., Martínez-Ramírez, I. J., Méndez, J., et al. (2023) · Revista Colombiana de Cardiología (English Edition) · doi:10.24875/rccare.m22000015
Propuesta de consenso y posición sobre hipertensión pulmonar 2022. Sociedad Peruana de Cardiología
Aguirre-Zurita, O., Cárdenas-Lévano, L. R., Correa-Flores, R. M., Diaz-Lazo, A. V., Sánchez, J. G. E., Salcedo, J. O. M., Pariona-Javier, M. L., Paucca-Montoya, E. R., Urteaga, Z. R., Pérez, E. S. S., et al. (2023) · Revista Peruana de Cardiología · doi:10.24875/rperc.m23000005
Menéndez, S. C. (2023) · Gredos (University of Salamanca) · doi:10.14201/gredos.153121
Klose, H. F. E., Harbaum, L., Richter, M. J., Lichtblau, M., Marra, A. M., Kabitz, H., Harutyunova, S., Milger, K., & Lange, T. J. (2023) · Pneumologie · doi:10.1055/a-2145-4711
ԹՈՔԱՅԻՆ ԶԱՐԿԵՐԱԿԱՅԻՆ ՀԻՊԵՐՏԵՆԶԻԱ
Minasyan, A., Khachatryan, T. A., Melkonyan, E. G., Meloyan, S. V., & Tavaratsyan, A. R. (2023) · MEDICINE SCIENCE AND EDUCATION · doi:10.56936/18291775-2023.36-16
Rosenkranz, S., Frantz, S., Dumitrescu, D., Eichstaedt, C. A., Ghofrani, H. A., Opitz, C. F., Wilkens, H., & Hoeper, M. M. (2023) · Die Kardiologie · doi:10.1007/s12181-023-00652-x
Self-citationYaqoob, M., DeCato, T. W., & Oudiz, R. J. (2024) · Current Respiratory Medicine Reviews · doi:10.2174/011573398x268093231226043639
Qian, J., Han, A., Shi, X., Chen, Y., Gao, Y., Wu, L., Ji, X., Sun, L., Shi, Y., Yang, Y., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3859956/v1
Lu, D., Zhang, J., Cheng, C., Yang, Y., Liu, T., Zhang, S., Qiu, B., Li, X., Guo, F., Li, J., et al. (2023) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2023-0918
Marqueurs pronostiques et stratification du risque dans l’HTAP
Boucly, A. (2021) · theses.fr (ABES) · doi:10.70675/5ed4fe2cz1e57z41c5zac6az4af0eec45aa6
León, J. S. T., Pedraza, M. P. M., Pedraza, J. A. N., Medina, N. J. M., Patiño, M. A. D., López, J. A. E., Vega, S. Y. V., Rivero, J., & Campo, E. R. Z. (2024) · Ciencia Latina Revista Científica Multidisciplinar · doi:10.37811/cl_rcm.v8i2.10294
Management of the Scleroderma Patient with Pulmonary Arterial Hypertension Failing Initial Therapy
Mullin, C. J., & Mathai, S. C. (2024) · Springer eBooks · doi:10.1007/978-3-031-40658-4_53
Risk Assessment in Pulmonary Veno-Occlusive Disease: The First Step Towards Future Trials?
Montani, D., Boucly, A., & Sitbon, O. (2024) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2024.04.011
OS PRINCIPAIS DESAFIOS E AS PERSPECTIVAS NO DIAGNÓSTICO E TRATAMENTO DA HIPERTENSÃO PULMONAR
Trindade, A. C., do Monte, B. B., de Andrade, B. V., Furquim, E. C. G., Filho, H. J. D. C. F., Ribeiro, I. G., de Miranda, M. G., Lima, M. D. A., & Uziel, S. (2024) · EPITAYA eBooks · doi:10.47879/ed.ep.2024479p349
Pineda, F. L., Vargas, C. A. P., Escobar, M. A., Gómez, A. S., Flórez, J. P., Muñoz-Ortiz, E., Ricardo, J. A. G., Sánchez, J. M. S., & Herrera, G. N. H. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4859904
Cersosimo, A., Barca, L., Condello, F., & Vizzardi, E. (2024) · Echocardiography · doi:10.1111/echo.15869
Advancements in Pulmonary Hypertension: Defining New Horizons!
Priya, S. N. S., & -, P. V. R. (2024) · International Journal of Science and Research (IJSR) · doi:10.21275/sr24701133656
Ding, H., Zhang, F., Zhong, J., Pan, J., Chen, Y., Zhang, J., Wang, Q., Liao, G., & Hao, Z. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1337243
Heine, A., Obst, A., Opitz, C. F., Halank, M., Richter, M. J., Lange, T. J., & Ewert, R. (2024) · Pneumologie · doi:10.1055/a-2472-0694
Self-citationThe state of database studies and future research
Meir, J., & Sreenivasan, J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-91790-2.00089-7
Gayen, S. K., Pescatore, J., Bittner, M., Naranjo, M., Criner, G. J., Weaver, S., D’Alonzo, G. E., Illipparambil, L. C., Rali, P. M., & Pourshahid, S. (2025) · BMC Pulmonary Medicine · doi:10.1186/s12890-025-03538-8
CDA-AMC (2025) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2025.1080
Gonçalves, A., Gonçalves, L. M. M., & Pinto, F. J. (2025) · Imprensa da Universidade de Coimbra eBooks · doi:10.14195/978-989-26-2420-4
Assad, A. P. L. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2024.tde-30042025-165146
Bozec, A. L., Cohen, S., Montani, D., Boucly, A., Guignabert, C., Roche, A., Kahf, S. A., Beurnier, A., Sitbon, O., Jaïs, X., et al. (2025) · ERJ Open Research · doi:10.1183/23120541.00110-2025
“Each patient ’ s risk status was evaluated using the European Society of Cardiology (ESC)/European Respiratory Society (ERS) four-strata risk status [9, 18] and the REVEAL Lite 2 risk score [19].”
The role of imaging in risk assessment for pulmonary arterial hypertension
Verma, D., Estrada, R. A., & Sahay, S. (2025) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001238
Al-Harbi, A., Biyari, A., Basuwdan, A., Alrodiman, O., Basuliman, A. S., & Alyousef, B. Y. (2025) · Respiratory Medicine · doi:10.1016/j.rmed.2025.108257
Systemic Sclerosis-Associated Pulmonary Hypertension: Three Cases with Distinct Hemodynamic Profiles
Maaroufi, A., Nawal, E., Mekouar, F., Mohammed, J., & Jamal, F. (2025) · Scholars Journal of Medical Case Reports · doi:10.36347/sjmcr.2025.v13i07.026
Grünig, E., Benjamin, N., Egenlauf, B., Harutyunova, S., Hess, V., Xanthouli, P., & Eichstaedt, C. A. (2025) · Zeitschrift für Pneumologie · doi:10.1007/s10405-025-00629-5
Self-citationPerna, E. R., Coronel, M. L., Secco, L., Talavera, M. L., Lescano, A. J., Lema, L. R., Calegari, E., Tuhay, G., Diez, A., Cáneva, J., et al. (2021) · Revista de la Federación Argentina de Cardiología · doi:10.63600/t8hwkp34
La mirada hacia el futuro: mensajes destacados del 7º Simposio Mundial de Hipertensión Pulmonar
Lema, L., Muñoz, L., Echazarreta, D. F., Lezcano, A., Diez, M., Campelo, N., & Haag, D. (2024) · Revista de la Federación Argentina de Cardiología · doi:10.63600/a8b25j41
Uygur, B., Sancar, K. M., Bulut, Ü., Kahraman, S., Ateşli, A., Demir, A. R., Ağuş, H. Z., Coşkun, G., Ertürk, M., & Yıldız, M. (2025) · Herz · doi:10.1007/s00059-025-05341-x
Cai, Z., Qi, X., Zhou, D., Dai, H., Yidilisi, A., Zhong, M., Deng, L., Guo, Y., Fan, J., Zhu, Q., et al. (2025) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2400057
“…group 1 PH, i.e., pul‐ monary arterial hypertension (PAH), from a reduction of a complex risk assessment algorithm (Galiè et al., 2016), and incorporated FC, 6MWD, and BNP/NT-proBNP in the final version since these parameters at follow-up are independent prognostic predictors (Hoeper et al., 2017).”
Risikostratifizierung und Behandlungsziele bei pulmonalarterieller Hypertonie
Olschewski, H., Barnikel, M., Pittrow, D., Schwaiblmair, M., Suleiman, M. N., Yogeswaran, A., Xanthouli, P., Gieseke, P., Douschan, P., Kaemmerer, A.-S., et al. (2025) · Pneumologie · doi:10.1055/a-2625-4844
Self-citationElectrical-mechanical dyssynchrony in pre-capillary pulmonary hypertension
Liu, B., Hu, E., Lin, X., Wu, W., Yang, Y., Yang, B.-L., Liang, Y.-R., Zeng, Q.-X., Yang, T., Zhao, Q., et al. (2025) · Herz · doi:10.1007/s00059-025-05343-9
Yang, L., Chen, D., Li, H., Pan, W., & Ge, J. (2025) · Cardiology · doi:10.1159/000548907
Dual Therapy for Initial Treatment of Adult Patients With Pulmonary Arterial Hypertension
CDA-AMC (2025) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2025.1262
Papa, S., D’Alto, M., Scelsi, L., Acquaro, M., Adamo, F. I., Albera, C., Ameri, P., Argiento, P., Badagliacca, R., CARIGNOLA, R., et al. (2025) · Vascular Pharmacology · doi:10.1016/j.vph.2025.107561
Self-citation骨髄系細胞におけるHypoxia‐inducible factor‐1αの欠損は低酸素誘発誘導性肺高血圧症を軽減させる
小嶋, 浩. (2020) · Institutional Repositories DataBase (IRDB) · doi:10.15017/4059951
Strategia terapeutica nei pazienti con ipertensione arteriosa polmonare a rischio intermedio
Dardi, F. (2021) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.48676/unibo/amsdottorato/9679
Triple combination therapy in pulmonary arterial hypertension
Zuffa, E. (2023) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.48676/unibo/amsdottorato/10604
Additional file 1 of Risk assessment in precapillary pulmonary hypertension: a comparative analysis
Sonnweber, T., Schneider, E.-M., Nairz, M., Theurl, I., Weiss, G., Tymoszuk, P., & Löffler‐Ragg, J. (2021) · Figshare · doi:10.6084/m9.figshare.13627213
Qu, J., Li, M., Zhang, X., Zhang, M., Zuo, X., Zhu, P., Ye, S., Zhang, W., Zheng, Y., 戚务芳, et al. (2023) · Figshare · doi:10.6084/m9.figshare.24115101
Benjamin, N. (2023) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00032713
Self-citationUllmann, E. (2021) · Gutenberg Open Science · doi:10.25358/openscience-5979
McGettrick, M. (2024) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.84238
Zhang, Y., Li, X., Jin, Q., Luo, Q., Zhao, Q., Yang, T., Qixian, Z., Yan, L., Duan, A., Huang, Z., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21557314
Sung, S.-H., Yeh, W.-Y., Chiang, C.-E., Huang, C.-J., Huang, W.-M., Chen, C.-H., & Cheng, H.-M. (2021) · Figshare · doi:10.6084/m9.figshare.16909597
Additional file 1 of The potential of cystatin C as a predictive biomarker in pulmonary hypertension
Duan, A., Huang, Z., Zhao, Z., Zhao, Q., Jin, Q., Yan, L., Zhang, Y., Li, X., Zhang, S., Hu, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26613062
Walthelm-Hösel, J. (2023) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-31439
Risk assessment in pulmonary hypertension
Stubbs, H. D. (2024) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.84813
Targeting the NLRP3 inflammasome as a novel approach for the treatment of pulmonary hypertension
Scott, T. (2020) · Figshare · doi:10.26180/13211918
Risk Assessment in Severe PH Due to ILD– A Cross Sectional Study
Ravi Kumar, P., & N., H. G. (2024) · International Journal of Pharmaceutical and Clinical Research · doi:10.5281/zenodo.14052409
Zhang, Y., Li, X., Jin, Q., Luo, Q., Zhao, Q., Yang, T., Qixian, Z., Yan, L., Duan, A., Huang, Z., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21557311
Zhang, Y., Li, X., Jin, Q., Luo, Q., Zhao, Q., Yang, T., Qixian, Z., Yan, L., Duan, A., Huang, Z., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21557317
Richter, M. J., & Justus Liebig University Giessen (2019) · University writing server of the Justus Liebig University Giessen (Justus-Liebig-Universität Gießen) · doi:10.22029/jlupub-14994
Qu, J., Li, M., Zhang, X., Zhang, M., Xx, Z., Zhu, P., Ye, S., Zhang, W., Zheng, Y., 戚务芳, et al. (2023) · Figshare · doi:10.6084/m9.figshare.24115104
Quan, R., Yang, Y., Yang, Z., Tian, H., Li, S., Shen, J., Ji, Y., 张刚成, 张曹进, Wang, G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14457237
Pulmonal arterielle Hypertonie bei Erwachsenen mit angeborenen Herzfehlern
Habdank, V., Tutarel, O., & München, T. U. (2023)
Role of Six transmembrane Protein of prostate 2 (Stamp2) in Experimental Pulmonary Hypertension
Batool, M. (2023) · Kölner Universitäts PublikationsServer (Universität zu Köln)
Cé, L. C. (2023) · Lume (Universidade Federal do Rio Grande do Sul)
de Andrade, O. G. C. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Arvidsson, M. (2024) · Lund University Publications (Lund University)
Metadata
- Authors
- Hoeper, M. M., Kramer, T., Pan, Z., Eichstaedt, C. A., Spiesshoefer, J., Benjamin, N., Olsson, K. M., Meyer, K., Vizza, C. D., Vonk-Noordegraaf, A., Distler, O., Opitz, C., Gibbs, J. S. R., Delcroix, M., Ghofrani, H. A., Huscher, D., Pittrow, D., Rosenkranz, S., & Grünig, E.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- University of Cologne (DE)
- University Hospital Heidelberg (DE)
- Heinrich Heine University Düsseldorf (DE)
- Sapienza University of Rome (IT)
- University Hospital Zurich (CH)
- DRK Kliniken Berlin (DE)
- Imperial College London (GB)
- Universitair Ziekenhuis Leuven (BE)
- Justus-Liebig-Universität Gießen (DE)
- Technische Universität Dresden (DE)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2017-08
- Volume
- 50
- Issue
- 2
- Pages
- 1700740
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2743897368
- Cited by
- 660
- References
- 21
- Citations by year
- 2026: 21 · 2025: 52 · 2024: 74 · 2023: 84 · 2022: 101 · 2021: 111 · 2020: 92 · 2019: 63 · 2018: 53 · 2017: 8
- FWCI
- 48.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Respiratory Journal (publishedVersion)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Lirias (KU Leuven) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- GlaxoSmithKline
- German Centre of Lung Research
- Bayer
- Actelion Pharmaceuticals
- Deutsche Forschungsgemeinschaft (HO 1599/2-1)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- pulmonary arterial hypertension, mortality prediction, risk stratification, one-year mortality, functional class, 6-minute walk distance, brain natriuretic peptide, right atrial pressure, cardiac index, mixed venous oxygen saturation
- MeSH terms
- Walk Test, Adult, Aged, Aged, 80 and over, Europe, Female, Hemodynamics, Humans, Hypertension, Pulmonary, Male, Middle Aged, Prospective Studies, Registries, Severity of Illness Index, Practice Guidelines as Topic, Risk Assessment, Natriuretic Peptide, Brain, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.